
Cat. #154443
E6/E7-HTE Cell Line
Cat. #: 154443
Unit size: 1x10^6 cells / vial
Availability: 8-10 weeks
Organism: Human
Tissue: Tonsil
Disease: Cancer
Model: Immortalised non-cancerous cell line
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Aloysius Klingelhutz
Institute: The University of Iowa
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: E6/E7-HTE Cell Line
- Alternate name: human tonsillar epithelial cell line
- Cancers detailed: Head;Neck;Oral
- Research fields: Cancer
- Organism: Human
- Tissue: Tonsil
- Disease: Cancer
- Model: Immortalised non-cancerous cell line
- Description: Model for HPV associated head and neck cancer. Used as an immortal adult human tonsillar epithelial cell line for pathogenesis and inflammation studies.
- Application: Used as an immortal adult human tonsillar epithelial cell line for pathogenesis and inflammation studies.
- Production details: G418 (requires feeders)
- Biosafety level: 1
Target Details
- Target: Used as an immortal adult human tonsillar epithelial cell line for pathogenesis and inflammation studies
Applications
- Application: Used as an immortal adult human tonsillar epithelial cell line for pathogenesis and inflammation studies.
Handling
- Format: Frozen
- Growth medium: Keratinocyte Serum Free Media
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
- Storage conditions: Liquid Nitrogen
- Mycoplasma free: Yes
References
- Spanos et al. 2008. Head Neck. 30(2):139-147. PMID: 17657785.
![Anti-CAR Whitlow Linker [1C3C3]](https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-300x322.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-280x300.jpg 280w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-954x1024.jpg 954w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025-768x824.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-6-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 1193w)

![Anti-CAR Whitlow Linker [1B4A1]](https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-300x396.jpg 300w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-227x300.jpg 227w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-776x1024.jpg 776w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025-768x1013.jpg 768w, https://cancertools.org/wp-content/uploads/Figure-5-Kimble-et-al.-J-Immunother-Cancer-2025.jpg 970w)


